Birdwatch Note
2024-08-15 21:53:08 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Les premiers cas de mpox sont apparus en 2022, ce qui a laissé le temps d'évaluer les vaccins existants (celui de la variole humaine est efficace), de développer des vaccins spécifiques (dont un est approuvé) et un traitement antiviral, mais aussi d'étudier sa transmission. https://www.pasteur.fr/fr/centre-medical/fiches-maladies/mpox-variole-du-singe https://sante.gouv.fr/soins-et-maladies/maladies/infections-sexuellement-transmissibles/article/virus-mpox-questions-reponses
Written by 215F3DD7D26FD48C493AD816BAAF6BE6BD20FC1D0712E0F2FE2AF074CA7E27C2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1824069192452076000
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1824202690408190065
- noteId - 1824202690408190065
- participantId -
- noteAuthorParticipantId - 215F3DD7D26FD48C493AD816BAAF6BE6BD20FC1D0712E0F2FE2AF074CA7E27C2
- createdAtMillis - 1723758788098
- tweetId - 1824069192452076000
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Les premiers cas de mpox sont apparus en 2022, ce qui a laissé le temps d'évaluer les vaccins existants (celui de la variole humaine est efficace), de développer des vaccins spécifiques (dont un est approuvé) et un traitement antiviral, mais aussi d'étudier sa transmission. https://www.pasteur.fr/fr/centre-medical/fiches-maladies/mpox-variole-du-singe https://sante.gouv.fr/soins-et-maladies/maladies/infections-sexuellement-transmissibles/article/virus-mpox-questions-reponses
Note Ratings
| rated at | rated by | |
| 2024-08-22 12:59:24 -0500 | Rating Details | |
| 2024-08-20 14:25:00 -0500 | Rating Details | |
| 2024-08-19 06:53:46 -0500 | Rating Details | |
| 2024-08-19 06:34:44 -0500 | Rating Details | |
| 2024-08-18 05:30:27 -0500 | Rating Details | |
| 2024-08-18 05:29:05 -0500 | Rating Details | |
| 2024-08-16 14:56:22 -0500 | Rating Details | |
| 2024-08-16 14:23:06 -0500 | Rating Details | |
| 2024-08-16 12:07:12 -0500 | Rating Details | |
| 2024-08-16 10:01:24 -0500 | Rating Details | |
| 2024-08-16 08:01:04 -0500 | Rating Details | |
| 2024-08-16 05:50:29 -0500 | Rating Details | |
| 2024-08-16 05:46:02 -0500 | Rating Details | |
| 2024-08-16 05:14:34 -0500 | Rating Details | |
| 2024-08-16 04:52:43 -0500 | Rating Details | |
| 2024-08-16 04:33:41 -0500 | Rating Details | |
| 2024-08-16 04:14:08 -0500 | Rating Details | |
| 2024-08-16 03:56:08 -0500 | Rating Details | |
| 2024-08-16 02:06:13 -0500 | Rating Details | |
| 2024-08-16 02:01:34 -0500 | Rating Details | |
| 2024-08-16 01:35:36 -0500 | Rating Details | |
| 2024-08-16 01:22:57 -0500 | Rating Details | |
| 2024-08-16 01:22:23 -0500 | Rating Details | |
| 2024-08-16 00:48:32 -0500 | Rating Details | |
| 2024-08-16 00:44:09 -0500 | Rating Details | |
| 2024-08-16 00:39:24 -0500 | Rating Details | |
| 2024-08-16 00:30:06 -0500 | Rating Details | |
| 2024-08-16 00:26:30 -0500 | Rating Details | |
| 2024-08-15 23:52:24 -0500 | Rating Details | |
| 2024-08-15 23:52:21 -0500 | Rating Details | |
| 2024-08-15 21:45:07 -0500 | Rating Details | |
| 2024-08-15 19:54:29 -0500 | Rating Details | |
| 2024-08-15 19:11:26 -0500 | Rating Details | |
| 2024-08-15 19:04:45 -0500 | Rating Details | |
| 2024-08-15 18:53:25 -0500 | Rating Details | |
| 2024-08-15 18:32:17 -0500 | Rating Details | |
| 2024-08-15 18:15:03 -0500 | Rating Details | |
| 2024-08-15 17:58:39 -0500 | Rating Details | |
| 2024-08-15 17:42:12 -0500 | Rating Details | |
| 2024-08-15 17:39:41 -0500 | Rating Details | |
| 2024-08-15 17:37:27 -0500 | Rating Details | |
| 2024-08-15 17:32:23 -0500 | Rating Details | |
| 2024-08-15 17:26:11 -0500 | Rating Details | |
| 2024-08-15 17:10:53 -0500 | Rating Details | |
| 2024-08-15 17:09:50 -0500 | Rating Details | |
| 2024-08-15 17:09:13 -0500 | Rating Details | |
| 2024-08-15 17:05:50 -0500 | Rating Details | |
| 2024-08-15 17:04:38 -0500 | Rating Details | |
| 2024-08-15 16:59:17 -0500 | Rating Details | |
| 2024-08-19 06:53:10 -0500 | Rating Details | |
| 2024-08-17 14:11:10 -0500 | Rating Details | |
| 2024-08-16 09:25:11 -0500 | Rating Details | |
| 2024-08-16 05:02:34 -0500 | Rating Details | |
| 2024-08-16 04:49:43 -0500 | Rating Details | |
| 2024-08-16 04:34:16 -0500 | Rating Details | |
| 2024-08-16 04:21:48 -0500 | Rating Details | |
| 2024-08-16 04:05:21 -0500 | Rating Details | |
| 2024-08-16 03:46:36 -0500 | Rating Details | |
| 2024-08-16 03:34:27 -0500 | Rating Details | |
| 2024-08-16 00:36:18 -0500 | Rating Details | |
| 2024-08-15 23:24:02 -0500 | Rating Details | |
| 2024-08-15 22:27:41 -0500 | Rating Details | |
| 2024-08-15 18:43:26 -0500 | Rating Details | |
| 2024-08-15 18:16:35 -0500 | Rating Details | |
| 2024-08-15 18:15:55 -0500 | Rating Details | |
| 2024-08-15 18:15:47 -0500 | Rating Details | |
| 2024-08-15 17:57:45 -0500 | Rating Details | |
| 2024-08-15 17:52:57 -0500 | Rating Details | |
| 2024-08-15 17:43:08 -0500 | Rating Details |